ArticleFrontiers in cardiovascular medicine2025
Nutritional support contributes to improving cardiac function and nutritional status in atrial fibrillation patients receiving treatment with esmolol hydrochloride.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: This study focused on the effect of nutritional support combined with esmolol hydrochloride on the efficacy, nutritional status and quality of life of patients with atrial fibrillation (AF). Methods: This retrospective cohort study categorised patients into a treatment group (TG) and a nursing group (NG) based on whether they received a high-quality care model, spanning the period from February 2021 to February 2024. Both groups received treatment with esmolol hydrochloride. The TG received standard care, while the NG received enhanced care (nutritional intervention + skin care) in addition to standard care. The study compared efficacy, cardiac function, nutritional status, adverse reactions, care satisfaction, and quality of life between the two groups. Result: Each group included 93 patients. The clinical efficacy of esmolol hydrochloride treatment in AF patients exceeds 90%, with nutritional care showing no significant enhancement of clinical outcomes ( Conclusion: Nutritional care administered alongside treatment with esmolol hydrochloride demonstrates superior efficacy in improving cardiac function, nutritional status, and quality of life among patients with AF.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.